1. Allison, A. C., and Byars, N. E., 1991, Immunological adjuvants: desirable properties and side-effects, Mol. Immunol.
28:279–284.
2. Arora, D. J. S., and Houde, M., 1988, Purified glycoproteins of influenza virus stimulate cell-mediated cytotoxicity in vivo, Nat. Immun. Cell Growth Reg.
7:87–94.
3. Arora, D. J. S., and Houde, M., 1992, Modulation of murine macrophage responses stimulated with influenza glycoproteins, Can. J. Microbiol.
38:188–192.
4. Claesson, B. A., Trolifors, B., Lagergard, T., Taranger, J., Bryla, D., Otterman, G., Cramton, T., Yang, Y., Reimer, C. B., Robbins, J. B., and Schneerson, R., 1988, Clinical and immunologic responses to the capsular Polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18-to 23-month-old children, J. Pediatr.
112:695–702.
5. Gall, D., 1966, The adjuvant activity of aliphatic nitrogenous bases, Immunology
11:369–386.